Travere Therapeutics, Inc. TVTX Pre-Tax Income
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s pre-tax income?
- Travere Therapeutics, Inc. (TVTX) reported pre-tax income of -$36.72M in Q1 2026.
- How has Travere Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Travere Therapeutics, Inc.'s pre-tax income increased by 10.8% year-over-year, from -$41.19M to -$36.72M.
- What is the long-term trend for Travere Therapeutics, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Travere Therapeutics, Inc.'s pre-tax income has grown at a -31.0% compound annual growth rate (CAGR), from -$216.88M to -$49.27M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.